Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.790
+0.010 (0.56%)
Oct 31, 2025, 12:29 PM EDT - Market open

Ernexa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
14151017217-
Upgrade
Market Cap Growth
128.85%55.53%-41.17%-92.39%--
Upgrade
Enterprise Value
1049456196-
Upgrade
Last Close Price
1.784.4126.9248.301251.00-
Upgrade
PS Ratio
10.5925.95142.82---
Upgrade
PB Ratio
3.008.884.351.368.51-
Upgrade
P/TBV Ratio
5.69-51.661.649.25-
Upgrade
EV/Sales Ratio
20.3583.40658.24---
Upgrade
Debt / Equity Ratio
0.130.4018.740.100.110.38
Upgrade
Asset Turnover
0.020.020.00---
Upgrade
Quick Ratio
1.690.741.221.624.810.52
Upgrade
Current Ratio
1.810.801.461.795.100.55
Upgrade
Return on Equity (ROE)
--2264.31%-302.20%-130.70%-739.07%-83.79%
Upgrade
Return on Assets (ROA)
-27.19%-39.64%-36.19%-63.25%-77.17%-32.34%
Upgrade
Return on Capital (ROIC)
-32.16%-46.41%-45.05%-81.98%-88.41%-43.53%
Upgrade
Earnings Yield
-320.19%-294.88%-223.12%-148.88%-56.47%-
Upgrade
FCF Yield
-105.80%-107.29%-210.34%-128.86%-10.89%-
Upgrade
Buyback Yield / Dilution
-704.66%-156.81%-74.17%-40.92%-146.19%-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q